← All organizations

Covis

For profitContributed to NME

Also known as: COVIS | COVIS PHARMA BV | Covis Pharma S.à.r.l.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

May 26, 2020

Acquired by Advanz Pharma on Jan 1, 2015

Timeline

1990s

Feb 2, 1995
nisoldipine— NDA Organization

2000s

Oct 20, 2006
ciclesonide— Marketing Organization

2010s

Jan 1, 2011
Covis— Founded
Jan 1, 2015
Advanz Pharma— Acquired By
Mar 29, 2019
formoterol— NDA Secondary Org

2020s

Nov 16, 2020
AMAG Pharmaceuticals, Inc.— Acquired

Drugs by trial phase (36 distinct, 63 trials)

Phase 4 (0 own, 5 via acquisition)

Phase 3 (1 own, 10 via acquisition)

Phase 2 (1 own, 14 via acquisition)

Phase 1 (0 own, 4 via acquisition)

Other trials (0 own, 1 via acquisition)

sodium chloride

Indications

Approved for

Studied for

Marketed drugs (12)

Subsidiaries (1 direct, 5 total across the full acquisition tree)

Recent trials (2)

NCT04377711Lead sponsorPhase 3May 26, 2020
NCT02688270Lead sponsorPhase 2Jun 1, 2016

Details

Founded: Zug, CH Jan 1, 2011
Last known activity: May 26, 2020

Designations held

Priority review